Zontivity OverviewVorapaxar (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co. Contents 1 Medical uses 2 Contraindications 3 Drug interactions 4 Dose adjustment 5 Mechanism of Action 6 Storage 7 History 8 References 9 External links Medical uses Vorapaxar is used for persons with a history of myocardial infarc...
Read more Zontivity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vorapaxar
Recent Zontivity Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 2.08mg, 2.5mg
NDC Database Records for Zontivity: (2 results)Sorted by National Drug Code
- 0006-0351 Zontivity 2.08 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
- 70347-208 Zontivity 2.08 mg Oral Tablet, Film Coated by Aralez Pharmaceuticals Us Inc.